P
Phinomics at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Phinomics takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions centre on building biotech companies, from the German biopharma ecosystem to what it really takes to grow a start-up inside an incubator. The incubator session is shared with Bayer.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
P Phinomics | |
Stanford spinout using AI-driven target and drug discovery around extrachromosomal circular DNA in cancer, with a European hub in Berlin. | Panel Tue Nov 10 09:30–09:55 Biopharma Ecosystem Germany: Spotlight on Innovation Drivers Ready for Take-Off Five teams from Germany's biotech scene, which spans university research, companies, drug manufacturing and healthcare, show their work and its impact. Panel Tue Nov 10 15:00–15:25 Inside the Incubator: What It Really Takes to Build a Biotech Company Today What incubators backed by big drug companies look for in young biotechs, and how they help founders with money, advice and partners. |
Instantly find 20 buyers from Phinomics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction